[帕金森病中的艺术和创造力:多巴胺的神秘效应]
E A Katunina1,2, Z A Zalyalova3,4, D V Pokhabov5,6
1Pirogov Russian National Research Medical University (Pirogov University), Moscow, Russia.
概括
对帕金森病 (PD) 的多巴胺治疗可以增强一些患者的创造力,这可能与冲动-强迫性障碍有关. 这种现象涉及增加动机和艺术风格的变化,但在科学文献中仍然存在争议.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 艺术治疗艺术治疗
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,主要影响运动功能.
- 一些患有PD的患者在多巴胺激素治疗期间表现出增强的创造能力.
- 这种现象可能与冲动-强迫性障碍 (ICD) 和多巴胺药物治疗有关.
研究的目的:
- 探索在接受治疗的帕金森病患者中创造性能力的出现和增强.
- 调查病原遗传原因和与ICD的联系.
- 分析影响创造力的因素,包括药物,遗传学和社会支持.
主要方法:
- 对患有PD的艺术家进行观察性研究.
- 分析患者的动机和创造性的产出.
- 对PD,创造力和多巴胺类疗法的现有文献的综述.
主要成果:
- 在一些PD患者中观察到与多巴胺类疗法相吻合的增强创造力和动机.
- 艺术风格的变化,包括强调颜色,抽象和改变的调色板.
- 艺术激情和ICD之间存在着一条细线,受药物剂量和个体特征的影响.
结论:
- 在治疗期间,PD患者的创造力出现是一个复杂的现象,可能与ICD有关.
- 虽然一些研究表明PD的分歧思维受损,但另一些研究则报告了增强的创造性产出.
- 药物,遗传学,认知功能和社会支持等因素显著影响PD患者的创造性表达.
相关概念视频
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Parkinson's Disease: Overview
319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Modeling in Therapy
33
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
33


